MSFT vs SSYS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
Stratasys exhibits severe operational weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating fundamentals. While the company maintains a strong balance sheet with very low debt (D/E 0.03) and high liquidity (Current Ratio 3.57), it is failing to translate this stability into profitability or growth. Revenue is contracting (-6.90% YoY) and the stock is in a long-term bearish trend, losing over 58% of its value over five years. The current valuation below book value (P/B 0.90) suggests a value play, but the lack of earnings growth makes it a likely value trap.
Compare Another Pair
Related Comparisons
MSFT vs SSYS: Head-to-Head Comparison
This page compares Microsoft Corporation (MSFT) and Stratasys Ltd. (SSYS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.